Wikipedia:WikiProject Medicine/Cochrane/Cochrane Review List/Brain Nerves and Mind

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Welcome Getting
Started
 WIKIPEDIAN
IN TRAINING RESOURCE
 Cochrane Reviews
on en.Wikipedia
 Cochrane Update
Project (english)
 Blogs Projects Cochrane Library Research Archive Questions  

Cochrane Brain, Nerves and Mind Network:
Reviews to be considered for Wikipedia

updated: November 2018'


Common Mental Disorders Group[edit]

Updated Jan 7 2020

 DoneAntidepressants for anorexia nervosa PMID 16437485 https://doi.org/10.1002/14651858.CD004365.pub2

 DoneAntidepressants for depression in older people PMID 16437456 https://doi.org/10.1002/14651858.CD003491.pub2

Antidepressants for depression in physically ill people PMID 20238354 https://doi.org/10.1002/14651858.CD007503.pub2

Antidepressants for preventing postnatal depression PMID 29669175 https://doi.org/10.1002/14651858.CD004363.pub3

Antidepressants plus benzodiazepines for adults with major depression PMID 31158298 https://doi.org/10.1002/14651858.CD001026.pub2

 DoneAntidepressants versus placebo for people with bulimia nervosa PMID 11687198 https://doi.org/10.1002/14651858.CD003391

 DoneAntidepressants versus psychological treatments and their combination for bulimia nervosa PMID 11687197 https://doi.org/10.1002/14651858.CD003385

Behavioural therapies versus other psychological therapies for depression PMID 24129886 https://doi.org/10.1002/14651858.CD008696.pub2

 DoneBenzodiazepines versus placebo for panic disorder in adults PMID 30921478 https://doi.org/10.1002/14651858.CD010677.pub2

Client feedback in psychological therapy for children and adolescents with mental health problems PMID 30124233 https://doi.org/10.1002/14651858.CD011729.pub2

 DoneCognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents PMID 27501438 https://doi.org/10.1002/14651858.CD003380.pub4

 DoneCognitive behavioural therapy for anxiety disorders in children and adolescents PMID 25692403 https://doi.org/10.1002/14651858.CD004690.pub4

Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia PMID 17253502 https://doi.org/10.1002/14651858.CD004364.pub2

 DoneCombined psychotherapy plus benzodiazepines for panic disorder PMID 19160253 https://doi.org/10.1002/14651858.CD005335.pub2

Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults PMID 31106850 https://doi.org/10.1002/14651858.CD012855.pub2

Consultation letters for medically unexplained physical symptoms in primary care PMID 21154369 https://doi.org/10.1002/14651858.CD006524.pub2

Continuation and maintenance treatments for depression in older people PMID 27609183 https://doi.org/10.1002/14651858.CD006727.pub3

Counselling for mental health and psychosocial problems in primary care PMID 21901675 https://doi.org/10.1002/14651858.CD001025.pub3

Couple and family therapies for post-traumatic stress disorder (PTSD) PMID 31797352 https://doi.org/10.1002/14651858.CD011257.pub2

Couple therapy for depression PMID 29882960 https://doi.org/10.1002/14651858.CD004188.pub3

Debriefing interventions for the prevention of psychological trauma in women following childbirth PMID 25858181 https://doi.org/10.1002/14651858.CD007194.pub2

Early psychological interventions to treat acute traumatic stress symptoms PMID 20238359 https://doi.org/10.1002/14651858.CD007944.pub2

E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions PMID 30110718 https://doi.org/10.1002/14651858.CD012489.pub2

 DoneElectroconvulsive therapy for the depressed elderly PMID 12804479 https://doi.org/10.1002/14651858.CD003593

Enhanced care by generalists for functional somatic symptoms and disorders in primary care PMID 24142886 https://doi.org/10.1002/14651858.CD008142.pub2

Escitalopram versus other antidepressive agents for depression PMID 19370639 https://doi.org/10.1002/14651858.CD006532.pub2

Exercise in prevention and treatment of anxiety and depression among children and young people PMID 16856055 https://doi.org/10.1002/14651858.CD004691.pub2

Family therapy for depression PMID 17636850 https://doi.org/10.1002/14651858.CD006728

Fluoxetine versus other types of pharmacotherapy for depression PMID 24353997 https://doi.org/10.1002/14651858.CD004185.pub3

Haloperidol alone or in combination for acute mania PMID 16856043 https://doi.org/10.1002/14651858.CD004362.pub2

Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa PMID 26212713 https://doi.org/10.1002/14651858.CD003909.pub2

Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders PMID 30663033 https://doi.org/10.1002/14651858.CD010827.pub2

Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults PMID 30550643 https://doi.org/10.1002/14651858.CD011710.pub2

Interventions for preventing eating disorders in children and adolescents PMID 12076457 https://doi.org/10.1002/14651858.CD002891

Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents PMID 23152246 https://doi.org/10.1002/14651858.CD007504.pub2

Interventions for primary prevention of suicide in university and other post-secondary educational settings PMID 25353703 https://doi.org/10.1002/14651858.CD009439.pub2

 DoneInterventions for self-harm in children and adolescents PMID 26688129 https://doi.org/10.1002/14651858.CD012013

Interventions to facilitate return to work in adults with adjustment disorders PMID 23235630 https://doi.org/10.1002/14651858.CD006389.pub2

Ketamine and other glutamate receptor modulators for depression in adults PMID 26395901 https://doi.org/10.1002/14651858.CD011612.pub2

Lithium for acute mania PMID 31152444 https://doi.org/10.1002/14651858.CD004048.pub4

Lithium versus antidepressants in the long-term treatment of unipolar affective disorder PMID 17054174 https://doi.org/10.1002/14651858.CD003492.pub2

Low dosage tricyclic antidepressants for depression PMID 12917952 https://doi.org/10.1002/14651858.CD003197

Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adults PMID 24018460 https://doi.org/10.1002/14651858.CD005330.pub4

Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults PMID 25362239 https://doi.org/10.1002/14651858.CD011142.pub2

Olanzapine alone or in combination for acute mania PMID 12918000 https://doi.org/10.1002/14651858.CD004040

Oxcarbazepine in the maintenance treatment of bipolar disorder PMID 18254071 https://doi.org/10.1002/14651858.CD005171.pub2

Paraprofessionals for anxiety and depressive disorders PMID 15846727 https://doi.org/10.1002/14651858.CD004688.pub2

Passiflora for anxiety disorder PMID 17253512 https://doi.org/10.1002/14651858.CD004518.pub2

Pharmacological interventions for somatoform disorders in adults PMID 25379990 https://doi.org/10.1002/14651858.CD010628.pub2

Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID 22071851 https://doi.org/10.1002/14651858.CD008483.pub2

Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease PMID 30566235 https://doi.org/10.1002/14651858.CD012346.pub2

Pharmacological interventions for treatment-resistant depression in adults PMID 31846068 https://doi.org/10.1002/14651858.CD010557.pub2

Pharmacotherapy and psychotherapy for body dysmorphic disorder PMID 19160252 https://doi.org/10.1002/14651858.CD005332.pub2

Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders PMID 17054260 https://doi.org/10.1002/14651858.CD005473.pub2

Pharmacotherapy for anxiety and comorbid alcohol use disorders PMID 25601826 https://doi.org/10.1002/14651858.CD007505.pub2

Pharmacotherapy for dysthymia PMID 12918001 https://doi.org/10.1002/14651858.CD004047

Pharmacy-based management for depression in adults PMID 31868236 https://doi.org/10.1002/14651858.CD013299.pub2

Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults PMID 31742672 https://doi.org/10.1002/14651858.CD012898.pub2

Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions PMID 30578633 https://doi.org/10.1002/14651858.CD012488.pub2

Psychological therapies for generalised anxiety disorder (GAD) PMID 17253466 https://doi.org/10.1002/14651858.CD001848.pub4

Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder PMID 27040448 https://doi.org/10.1002/14651858.CD010204.pub2

Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID 28322440 https://doi.org/10.1002/14651858.CD010673.pub2

Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease PMID 30838649 https://doi.org/10.1002/14651858.CD012347.pub2

Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises PMID 29975811 https://doi.org/10.1002/14651858.CD011849.pub2

Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults PMID 27730622 https://doi.org/10.1002/14651858.CD011170.pub2

Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD) PMID 17443583 https://doi.org/10.1002/14651858.CD005333.pub2

Psychological, social and welfare interventions for psychological health and well-being of torture survivors PMID 25386846 https://doi.org/10.1002/14651858.CD009317.pub2

Psychosocial interventions for prevention of psychological disorders in law enforcement officers PMID 18646132 https://doi.org/10.1002/14651858.CD005601.pub2

Psychosocial interventions for self-harm in adults PMID 27168519 https://doi.org/10.1002/14651858.CD012189

Relaxation for depression PMID 18843744 https://doi.org/10.1002/14651858.CD007142.pub2

Risperidone alone or in combination for acute mania PMID 16437472 https://doi.org/10.1002/14651858.CD004043.pub2

Risperidone in long-term treatment for bipolar disorder PMID 17054229 https://doi.org/10.1002/14651858.CD004999.pub2

Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults PMID 27409972 https://doi.org/10.1002/14651858.CD011119.pub2

Second-generation antipsychotics for anxiety disorders PMID 21154392 https://doi.org/10.1002/14651858.CD008120.pub2

Therapeutic touch for anxiety disorders PMID 17636838 https://doi.org/10.1002/14651858.CD006240.pub2

Tiagabine for acute affective episodes in bipolar disorder PMID 23235614 https://doi.org/10.1002/14651858.CD004694.pub3

Tiagabine in the maintenance treatment of bipolar disorder PMID 22161389 https://doi.org/10.1002/14651858.CD005173.pub3

Transcranial magnetic stimulation for the treatment of obsessive compulsive disorder (OCD) PMID 12917964 https://doi.org/10.1002/14651858.CD003387

Transcranial magnetic stimulation for treating depression PMID 12076483 https://doi.org/10.1002/14651858.CD003493

Tricyclic drugs for depression in children and adolescents PMID 23780719 https://doi.org/10.1002/14651858.CD002317.pub2

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder PMID 24132760 https://doi.org/10.1002/14651858.CD003196.pub2

Vortioxetine for depression in adults PMID 28677828 https://doi.org/10.1002/14651858.CD011520.pub2

Dementia and Cognitive Improvement Group[edit]

Update: Jan 7 2020

 Done18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164600 https://doi.org/10.1002/14651858.CD012883

18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164603 https://doi.org/10.1002/14651858.CD012216.pub2

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164602 https://doi.org/10.1002/14651858.CD012884

AD-8 for detection of dementia across a variety of healthcare settings PMID 30828783 https://doi.org/10.1002/14651858.CD011121.pub2

Addenbrooke’s Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment PMID 31846066 https://doi.org/10.1002/14651858.CD013282.pub2

 DoneAerobic exercise to improve cognitive function in older people without known cognitive impairment PMID 25900537 https://doi.org/10.1002/14651858.CD005381.pub4

Almitrine-Raubasine combination for dementia PMID 21412915 https://doi.org/10.1002/14651858.CD008068.pub2

Alpha lipoic acid for dementia PMID 14974062 https://doi.org/10.1002/14651858.CD004244.pub2

Animal-assisted therapy for dementia PMID 31763689 https://doi.org/10.1002/14651858.CD013243.pub2

Art therapy for people with dementia PMID 30215847 https://doi.org/10.1002/14651858.CD011073.pub2

Assistive technology for memory support in dementia PMID 28602027 https://doi.org/10.1002/14651858.CD009627.pub2

Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment PMID 21491398 https://doi.org/10.1002/14651858.CD007220.pub2

Case management approaches to home support for people with dementia PMID 25560977 https://doi.org/10.1002/14651858.CD008345.pub2

Cholinesterase inhibitors for delirium PMID 18254077 https://doi.org/10.1002/14651858.CD005317.pub2

Cholinesterase inhibitors for dementia with Lewy bodies PMID 12917981 https://doi.org/10.1002/14651858.CD003672

Cholinesterase inhibitors for mild cognitive impairment PMID 22972133 https://doi.org/10.1002/14651858.CD009132.pub2

Cholinesterase inhibitors for Parkinson's disease dementia PMID 16437494 https://doi.org/10.1002/14651858.CD004747.pub2

Cholinesterase inhibitors for rarer dementias associated with neurological conditions PMID 25734590 https://doi.org/10.1002/14651858.CD009444.pub3

Cholinesterase inhibitors for the treatment of delirium in non-ICU settings PMID 29952000 https://doi.org/10.1002/14651858.CD012494.pub2

Cognitive training and cognitive rehabilitation for older adults with mild to moderate dementia PMID 23740535 https://doi.org/10.1002/14651858.CD003260.pub2

Cognitive training for older people and people with mild cognitive impairment PMID 21249675 https://doi.org/10.1002/14651858.CD006220.pub2

Cognitive training for people with mild to moderate dementia PMID 30909318 https://doi.org/10.1002/14651858.CD013069.pub2

Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life PMID 30864187 https://doi.org/10.1002/14651858.CD012277.pub2

Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife PMID 30864746 https://doi.org/10.1002/14651858.CD012278.pub2

Computerised cognitive training for preventing dementia in people with mild cognitive impairment PMID 30864747 https://doi.org/10.1002/14651858.CD012279.pub2

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 28328043 https://doi.org/10.1002/14651858.CD010803.pub2

Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly PMID 15846601 https://doi.org/10.1002/14651858.CD000269.pub3

D-cycloserine for Alzheimer's disease PMID 12076471 https://doi.org/10.1002/14651858.CD003153

Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies PMID 25632881 https://doi.org/10.1002/14651858.CD010633.pub2

Driving assessment for maintaining mobility and safety in drivers with dementia PMID 23990315 https://doi.org/10.1002/14651858.CD006222.pub4

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia PMID 28617932 https://doi.org/10.1002/14651858.CD003804.pub2

Efficacy and experiences of telephone counselling for informal carers of people with dementia PMID 25177838 https://doi.org/10.1002/14651858.CD009126.pub2

Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH) PMID 26222251 https://doi.org/10.1002/14651858.CD010033.pub2

Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery PMID 26074478 https://doi.org/10.1002/14651858.CD010569.pub2

Environmental and behavioural modifications for improving food and fluid intake in people with dementia PMID 30021248 https://doi.org/10.1002/14651858.CD011542.pub2

Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus PMID 23728696 https://doi.org/10.1002/14651858.CD009706.pub2

Functional analysis-based interventions for challenging behaviour in dementia PMID 22336826 https://doi.org/10.1002/14651858.CD006929.pub2

Galantamine for vascular cognitive impairment PMID 16437493 https://doi.org/10.1002/14651858.CD004746.pub2

Haloperidol for agitation in dementia PMID 11687166 https://doi.org/10.1002/14651858.CD002852

Hormone replacement therapy for cognitive function in postmenopausal women PMID 18254016 https://doi.org/10.1002/14651858.CD003122.pub2

Hormone replacement therapy to maintain cognitive function in women with dementia PMID 19160224 https://doi.org/10.1002/14651858.CD003799.pub2

Huperzine A for mild cognitive impairment PMID 23235666 https://doi.org/10.1002/14651858.CD008827.pub2

Huperzine A for vascular dementia PMID 19370686 https://doi.org/10.1002/14651858.CD007365.pub2

Hydergine for dementia PMID 10796534 https://doi.org/10.1002/14651858.CD000359

Hyperbaric oxygen therapy for vascular dementia PMID 22786527 https://doi.org/10.1002/14651858.CD009425.pub2

Ibuprofen for Alzheimer's disease PMID 12804498 https://doi.org/10.1002/14651858.CD004031

Indomethacin for Alzheimer's disease PMID 12076498 https://doi.org/10.1002/14651858.CD003673

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting PMID 24990271 https://doi.org/10.1002/14651858.CD010771.pub2

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting PMID 25754745 https://doi.org/10.1002/14651858.CD010772.pub2

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations PMID 24719028 https://doi.org/10.1002/14651858.CD010079.pub2

Interventions for preventing and reducing the use of physical restraints in long-term geriatric care PMID 21328295 https://doi.org/10.1002/14651858.CD007546.pub2

Interventions for preventing delirium in older people in institutional long-term care PMID 31012953 https://doi.org/10.1002/14651858.CD009537.pub3

L-carnitine for cognitive enhancement in people without cognitive impairment PMID 28349514 https://doi.org/10.1002/14651858.CD009374.pub3

Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia PMID 24574061 https://doi.org/10.1002/14651858.CD003946.pub4

Melatonin for the treatment of dementia PMID 16437462 https://doi.org/10.1002/14651858.CD003802.pub3

Metal protein attenuating compounds for the treatment of Alzheimer's dementia PMID 24563468 https://doi.org/10.1002/14651858.CD005380.pub5

Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting PMID 29470861 https://doi.org/10.1002/14651858.CD011415.pub2

Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting PMID 31521064 https://doi.org/10.1002/14651858.CD011414.pub2

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting PMID 25922857 https://doi.org/10.1002/14651858.CD010860.pub2

Modifying the consistency of food and fluids for swallowing difficulties in dementia PMID 30251253 https://doi.org/10.1002/14651858.CD011077.pub2

Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias PMID 26513331 https://doi.org/10.1002/14651858.CD010775.pub2

Naftidrofuryl for dementia PMID 22161372 https://doi.org/10.1002/14651858.CD002955.pub4

Nicotine for Alzheimer's disease PMID 10796667 https://doi.org/10.1002/14651858.CD001749

Nimodipine for primary degenerative, mixed and vascular dementia PMID 10796495 https://doi.org/10.1002/14651858.CD000147

Omega 3 fatty acid for the prevention of cognitive decline and dementia PMID 22696350 https://doi.org/10.1002/14651858.CD005379.pub3

Opioids for agitation in dementia PMID 25972091 https://doi.org/10.1002/14651858.CD009705.pub2

Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care PMID 29438597 https://doi.org/10.1002/14651858.CD009812.pub2

Pharmacological interventions for apathy in Alzheimer's disease PMID 29727467 https://doi.org/10.1002/14651858.CD012197.pub2

Pharmacological treatment of hypertension in patients without prior cerebrovascular disease for the prevention of cognitive impairment and dementia PMID 19821318 https://doi.org/10.1002/14651858.CD004034.pub3

Pharmacotherapy for chronic cognitive impairment in traumatic brain injury PMID 26624881 https://doi.org/10.1002/14651858.CD009221.pub2

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 24913723 https://doi.org/10.1002/14651858.CD008782.pub4

Procaine treatments for cognition and dementia PMID 18843698 https://doi.org/10.1002/14651858.CD005993.pub2

Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia PMID 26102272 https://doi.org/10.1002/14651858.CD010896.pub2

Rivastigmine for vascular cognitive impairment PMID 23728651 https://doi.org/10.1002/14651858.CD004744.pub3

Selegiline for Alzheimer's disease PMID 10796544 https://doi.org/10.1002/14651858.CD000442

Shunting for normal pressure hydrocephalus (NPH) PMID 12137677 https://doi.org/10.1002/14651858.CD003157

Simulated presence therapy for dementia PMID 28418586 https://doi.org/10.1002/14651858.CD011882.pub2

Special care units for dementia individuals with behavioural problems PMID 19821370 https://doi.org/10.1002/14651858.CD006470.pub2

Statin withdrawal in people with dementia PMID 27610945 https://doi.org/10.1002/14651858.CD012050.pub2

Statins for the prevention of dementia PMID 26727124 https://doi.org/10.1002/14651858.CD003160.pub3

Subjective barriers to prevent wandering of cognitively impaired people PMID 11034735 https://doi.org/10.1002/14651858.CD001932

Thiamine for Alzheimer's disease PMID 10796655 https://doi.org/10.1002/14651858.CD001498

Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol PMID 23818100 https://doi.org/10.1002/14651858.CD004033.pub3

Traditional Chinese herbal medicine for vascular dementia PMID 30520514 https://doi.org/10.1002/14651858.CD010284.pub2

Transcutaneous Electrical Nerve Stimulation (TENS) for dementia PMID 12917999 https://doi.org/10.1002/14651858.CD004032

Trazodone for agitation in dementia PMID 15495135 https://doi.org/10.1002/14651858.CD004990

Velnacrine for Alzheimer's disease PMID 15106259 https://doi.org/10.1002/14651858.CD004748

Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life PMID 30556597 https://doi.org/10.1002/14651858.CD011906.pub2

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment PMID 30383288 https://doi.org/10.1002/14651858.CD011905.pub2

Vitamin B12 for cognition PMID 12918013 https://doi.org/10.1002/14651858.CD004394

Vitamin B6 for cognition PMID 14584010 https://doi.org/10.1002/14651858.CD004393

Zhiling decoction for vascular dementia PMID 15495123 https://doi.org/10.1002/14651858.CD004670.pub2

Developmental, Psychosocial and Learning Problems Group[edit]

Update: Jan 7 2020

 DoneA realist review of which advocacy interventions work for which abused women under what circumstances PMID 31254283 https://doi.org/10.1002/14651858.CD013135.pub2

Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well-being of women who experience intimate partner abuse PMID 26632986 https://doi.org/10.1002/14651858.CD005043.pub3

Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities PMID 19160313 https://doi.org/10.1002/14651858.CD007009.pub2

Antiepileptics for aggression and associated impulsivity PMID 20166067 https://doi.org/10.1002/14651858.CD003499.pub3

 DoneAntipsychotic medication for challenging behaviour in people with learning disability PMID 15266428 https://doi.org/10.1002/14651858.CD000377.pub2

Auditory-verbal therapy for promoting spoken language development in children with permanent hearing impairments PMID 24619508 https://doi.org/10.1002/14651858.CD010100.pub2

Beginning reading interventions for children and adolescents with intellectual disability PMID 31805208 https://doi.org/10.1002/14651858.CD011359.pub2

Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years PMID 22336837 https://doi.org/10.1002/14651858.CD008225.pub2

Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with intellectual disabilities PMID 25847633 https://doi.org/10.1002/14651858.CD003406.pub4

Bright light therapy for sleep problems in adults aged 60+ PMID 12076478 https://doi.org/10.1002/14651858.CD003403

Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors PMID undefined https://doi.org/10.1002/14651858.CD012547.pub2

Centre-based day care for children younger than five years of age in high-income countries PMID 25247266 https://doi.org/10.1002/14651858.CD010544.pub2

Centre-based day care for children younger than five years of age in low- and middle-income countries PMID 25254354 https://doi.org/10.1002/14651858.CD010543.pub2

Clozapine for psychotic disorders in adults with intellectual disabilities PMID 26397173 https://doi.org/10.1002/14651858.CD010625.pub2

Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults PMID 29566425 https://doi.org/10.1002/14651858.CD010840.pub2

Cognitive-behavioural interventions for children who have been sexually abused PMID 22592679 https://doi.org/10.1002/14651858.CD001930.pub3

Cognitive-behavioural interventions for preventing youth gang involvement for children and young people (7-16) PMID 18425976 https://doi.org/10.1002/14651858.CD007008.pub2

Communication interventions for autism spectrum disorder in minimally verbal children PMID 30395694 https://doi.org/10.1002/14651858.CD012324.pub2

Community-based supplementary feeding for food insecure, vulnerable and malnourished populations – an overview of systematic reviews PMID 30480324 https://doi.org/10.1002/14651858.CD010578.pub2

Crisis interventions for people with borderline personality disorder PMID 22696385 https://doi.org/10.1002/14651858.CD009353.pub2

Daily iron supplementation for improving anaemia, iron status and health in menstruating women PMID 27087396 https://doi.org/10.1002/14651858.CD009747.pub2

De-escalation techniques for managing non-psychosis induced aggression in adults PMID 30019748 https://doi.org/10.1002/14651858.CD012034.pub2

Dietary modifications for infantile colic PMID 30306546 https://doi.org/10.1002/14651858.CD011029.pub2

Educational and skills-based interventions for preventing relationship and dating violence in adolescents and young adults PMID 23780745 https://doi.org/10.1002/14651858.CD004534.pub3

Effectiveness of provision of animal-source foods for supporting optimal growth and development in children 6 to 59 months of age PMID 30779870 https://doi.org/10.1002/14651858.CD012818.pub2

Electropalatography for articulation disorders associated with cleft palate PMID 19588407 https://doi.org/10.1002/14651858.CD006854.pub2

Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis PMID 31858595 https://doi.org/10.1002/14651858.CD011780.pub2

Exercise to improve self-esteem in children and young people PMID 14974029 https://doi.org/10.1002/14651858.CD003683.pub2

Families and Schools Together (FAST) for improving outcomes for children and their families PMID 31425610 https://doi.org/10.1002/14651858.CD012760.pub2

Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17 PMID 11406062 https://doi.org/10.1002/14651858.CD003015

Family therapy for autism spectrum disorders PMID 28509404 https://doi.org/10.1002/14651858.CD011894.pub2

Financial benefits for child health and well-being in low income or socially disadvantaged families in developed world countries PMID 18425950 https://doi.org/10.1002/14651858.CD006358.pub2

Fundoplication versus postoperative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy PMID 23986351 https://doi.org/10.1002/14651858.CD006151.pub3

Group-based parent training programmes for improving emotional and behavioural adjustment in young children PMID 27478983 https://doi.org/10.1002/14651858.CD003680.pub3

Group-based parent training programmes for improving parental psychosocial health PMID 24838729 https://doi.org/10.1002/14651858.CD002020.pub4

Home-based child development interventions for preschool children from socially disadvantaged families PMID 22161419 https://doi.org/10.1002/14651858.CD008131.pub2

Independent living programmes for improving outcomes for young people leaving the care system PMID 16856104 https://doi.org/10.1002/14651858.CD005558.pub2

Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children PMID 21412881 https://doi.org/10.1002/14651858.CD002964.pub2

Individual and group-based parenting programmes for the treatment of physical child abuse and neglect PMID 16856097 https://doi.org/10.1002/14651858.CD005463.pub2

Intermittent iron supplementation for improving nutrition and development in children under 12 years of age PMID 22161444 https://doi.org/10.1002/14651858.CD009085.pub2

Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women PMID 30699468 https://doi.org/10.1002/14651858.CD009218.pub3

Intervention for dysarthria associated with acquired brain injury in children and adolescents PMID 18646143 https://doi.org/10.1002/14651858.CD006279.pub2

Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD) PMID 24652601 https://doi.org/10.1002/14651858.CD008785.pub2

Interventions for childhood apraxia of speech PMID 29845607 https://doi.org/10.1002/14651858.CD006278.pub3

Interventions for learning disabled sex offenders PMID 18254027 https://doi.org/10.1002/14651858.CD003682.pub2

Interventions for oropharyngeal dysphagia in children with neurological impairment PMID 23076958 https://doi.org/10.1002/14651858.CD009456.pub2

Intravenous secretin for autism spectrum disorders (ASD) PMID 22513913 https://doi.org/10.1002/14651858.CD003495.pub3

Iron supplementation for breath-holding attacks in children PMID 20464763 https://doi.org/10.1002/14651858.CD008132.pub2

Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia PMID 23744449 https://doi.org/10.1002/14651858.CD001444.pub2

Kinship care for the safety, permanency, and well-being of children removed from the home for maltreatment PMID 24488572 https://doi.org/10.1002/14651858.CD006546.pub3

Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes PMID 30168868 https://doi.org/10.1002/14651858.CD012610.pub2

Media-based behavioural treatments for behavioural problems in children PMID 16437442 https://doi.org/10.1002/14651858.CD002206.pub3

Melatonin for non-respiratory sleep disorders in visually impaired children PMID 22071850 https://doi.org/10.1002/14651858.CD008473.pub2

Non-speech oral motor treatment for children with developmental speech sound disorders PMID 25805060 https://doi.org/10.1002/14651858.CD009383.pub2

Opportunities provision for preventing youth gang involvement for children and young people (7-16) PMID 18425975 https://doi.org/10.1002/14651858.CD007002.pub2

Parent training interventions for parents with intellectual disability PMID 30004571 https://doi.org/10.1002/14651858.CD007987.pub3

Parent training programmes for managing infantile colic PMID 31794639 https://doi.org/10.1002/14651858.CD012459.pub2

Parent-infant psychotherapy for improving parental and infant mental health PMID 25569177 https://doi.org/10.1002/14651858.CD010534.pub2

Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders PMID 30040119 https://doi.org/10.1002/14651858.CD012507.pub2

Parent-mediated interventions for promoting communication and language development in young children with Down syndrome PMID 30321454 https://doi.org/10.1002/14651858.CD012089.pub2

Personal assistance for adults (19-64) with both physical and intellectual impairments PMID 18425973 https://doi.org/10.1002/14651858.CD006860.pub2

Personal assistance for adults (19-64) with physical impairments PMID 18646171 https://doi.org/10.1002/14651858.CD006856.pub2

Personal assistance for children and adolescents (0-18) with both physical and intellectual impairments PMID 18646173 https://doi.org/10.1002/14651858.CD006859.pub2

Personal assistance for children and adolescents (0-18) with intellectual impairments PMID 18646172 https://doi.org/10.1002/14651858.CD006858.pub2

Personal assistance for children and adolescents (0-18) with physical impairments PMID 18646141 https://doi.org/10.1002/14651858.CD006277.pub2

Pharmacological interventions for cognitive decline in people with Down syndrome PMID 26513128 https://doi.org/10.1002/14651858.CD011546.pub2

Pharmacological interventions for recurrent abdominal pain in childhood PMID 28262913 https://doi.org/10.1002/14651858.CD010973.pub2

Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities PMID 23633366 https://doi.org/10.1002/14651858.CD009084.pub2

Phonics training for English-speaking poor readers PMID 30480759 https://doi.org/10.1002/14651858.CD009115.pub3

Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight PMID 29499084 https://doi.org/10.1002/14651858.CD009728.pub4

Physical exercise for sleep problems in adults aged 60+ PMID 12519595 https://doi.org/10.1002/14651858.CD003404

Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age PMID 29168569 https://doi.org/10.1002/14651858.CD009666.pub2

Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes PMID 31046132 https://doi.org/10.1002/14651858.CD012611.pub3

Probiotics to prevent infantile colic PMID 30865287 https://doi.org/10.1002/14651858.CD012473.pub2

Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused PMID 23904184 https://doi.org/10.1002/14651858.CD008162.pub2

Psychosocial interventions for recurrent abdominal pain in childhood PMID 28072460 https://doi.org/10.1002/14651858.CD010971.pub2

Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities PMID 19370667 https://doi.org/10.1002/14651858.CD007011.pub2

 DoneRisperidone for autism spectrum disorder PMID 17253538 https://doi.org/10.1002/14651858.CD005040.pub2

School feeding for improving the physical and psychosocial health of disadvantaged students PMID 17253518 https://doi.org/10.1002/14651858.CD004676.pub2

School-based education programmes for the prevention of child sexual abuse PMID 25876919 https://doi.org/10.1002/14651858.CD004380.pub3

Screening women for intimate partner violence in healthcare settings PMID 26200817 https://doi.org/10.1002/14651858.CD007007.pub3

Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis PMID 31801180 https://doi.org/10.1002/14651858.CD011260.pub2

Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD) PMID 22786515 https://doi.org/10.1002/14651858.CD008511.pub2

Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years PMID 31222721 https://doi.org/10.1002/14651858.CD008223.pub3

Specialist home-based nursing services for children with acute and chronic illnesses PMID 23771694 https://doi.org/10.1002/14651858.CD004383.pub3

Supplementary vitamin E, selenium, cysteine and riboflavin for preventing kwashiorkor in preschool children in developing countries PMID 20393967 https://doi.org/10.1002/14651858.CD008147.pub2

Task-oriented interventions for children with developmental co-ordination disorder PMID 28758189 https://doi.org/10.1002/14651858.CD010914.pub2

The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants PMID 29537066 https://doi.org/10.1002/14651858.CD011754.pub2

The WHO Health Promoting School framework for improving the health and well-being of students and their academic achievement PMID 24737131 https://doi.org/10.1002/14651858.CD008958.pub2

Treadmill interventions in children under six years of age at risk of neuromotor delay PMID 28755534 https://doi.org/10.1002/14651858.CD009242.pub3

Treatment Foster Care for improving outcomes in children and young people PMID 18254087 https://doi.org/10.1002/14651858.CD005649.pub2

Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents PMID 22419332 https://doi.org/10.1002/14651858.CD008372.pub2

Trihexyphenidyl for dystonia in cerebral palsy PMID 29763510 https://doi.org/10.1002/14651858.CD012430.pub2

Video feedback for parental sensitivity and attachment security in children under five years PMID 31782528 https://doi.org/10.1002/14651858.CD012348.pub2

Zinc supplementation for mental and motor development in children PMID 23235652 https://doi.org/10.1002/14651858.CD007991.pub2

Drugs and Alcohol Group[edit]

Updated Jan 7 2020

Anticonvulsants for alcohol dependence PMID 24523233 https://doi.org/10.1002/14651858.CD008544.pub2

Baclofen for alcohol use disorder PMID 30484285 https://doi.org/10.1002/14651858.CD012557.pub2

Brief interventions for heavy alcohol users admitted to general hospital wards PMID 21833953 https://doi.org/10.1002/14651858.CD005191.pub3

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders PMID 30577083 https://doi.org/10.1002/14651858.CD011315.pub2

Detoxification treatments for opiate dependent adolescents PMID 24777492 https://doi.org/10.1002/14651858.CD006749.pub3

Disulfiram for the treatment of cocaine dependence PMID 20091613 https://doi.org/10.1002/14651858.CD007024.pub2

Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome PMID 21678378 https://doi.org/10.1002/14651858.CD008537.pub2

Family-based prevention programmes for alcohol use in young people PMID 30888061 https://doi.org/10.1002/14651858.CD012287.pub2

Inpatient versus other settings for detoxification for opioid dependence PMID 15846721 https://doi.org/10.1002/14651858.CD004580.pub2

Interventions for drug-using offenders with co-occurring mental health problems PMID 31588993 https://doi.org/10.1002/14651858.CD010901.pub3

Interventions for female drug-using offenders PMID 31834635 https://doi.org/10.1002/14651858.CD010910.pub3

Interventions for prevention of drug use by young people delivered in non-school settings PMID 16437511 https://doi.org/10.1002/14651858.CD005030.pub2

LAAM maintenance vs methadone maintenance for heroin dependence PMID 12076441 https://doi.org/10.1002/14651858.CD002210

Magnesium for alcohol withdrawal PMID 23740536 https://doi.org/10.1002/14651858.CD008358.pub2

Maintenance agonist treatments for opiate-dependent pregnant women PMID 24366859 https://doi.org/10.1002/14651858.CD006318.pub3

Maintenance treatments for opiate-dependent adolescents PMID 24957634 https://doi.org/10.1002/14651858.CD007210.pub3

Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse PMID 23235633 https://doi.org/10.1002/14651858.CD006747.pub2

Media campaigns for the prevention of illicit drug use in young people PMID 23740538 https://doi.org/10.1002/14651858.CD009287.pub2

Mentoring adolescents to prevent drug and alcohol use PMID 22071836 https://doi.org/10.1002/14651858.CD007381.pub2

Methadone at tapered doses for the management of opioid withdrawal PMID 23450540 https://doi.org/10.1002/14651858.CD003409.pub4

Methadone maintenance at different dosages for opioid dependence PMID 12917925 https://doi.org/10.1002/14651858.CD002208

Motivational interviewing for substance abuse PMID 21563163 https://doi.org/10.1002/14651858.CD008063.pub2

Motivational interviewing for the prevention of alcohol misuse in young adults PMID 27426026 https://doi.org/10.1002/14651858.CD007025.pub4

Opioid agonist treatment for pharmaceutical opioid dependent people PMID 27157143 https://doi.org/10.1002/14651858.CD011117.pub2

Oral substitution treatment of injecting opioid users for prevention of HIV infection PMID 21833948 https://doi.org/10.1002/14651858.CD004145.pub4

Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment PMID 19588428 https://doi.org/10.1002/14651858.CD007361.pub2

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users PMID 29543325 https://doi.org/10.1002/14651858.CD011481.pub2

Pharmacological interventions for drug-using offenders PMID 26035084 https://doi.org/10.1002/14651858.CD010862.pub2

Pharmacological therapies for maintenance treatments of opium dependence PMID 23440817 https://doi.org/10.1002/14651858.CD007775.pub2

Pharmacological treatment for depression during opioid agonist treatment for opioid dependence PMID 20824876 https://doi.org/10.1002/14651858.CD008373.pub2

Psychological interventions for co-occurring depression and substance use disorders PMID 31769015 https://doi.org/10.1002/14651858.CD009501.pub2

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification PMID 21901695 https://doi.org/10.1002/14651858.CD005031.pub4

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence PMID 21975742 https://doi.org/10.1002/14651858.CD004147.pub4

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence PMID 26106751 https://doi.org/10.1002/14651858.CD009652.pub2

Psychosocial interventions for cannabis use disorder PMID 27149547 https://doi.org/10.1002/14651858.CD005336.pub4

Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions PMID 25835053 https://doi.org/10.1002/14651858.CD006037.pub3

Psychosocial interventions for psychostimulant misuse PMID 27684277 https://doi.org/10.1002/14651858.CD011866.pub2

Psychosocial interventions for women enrolled in alcohol treatment during pregnancy PMID 18646166 https://doi.org/10.1002/14651858.CD006753.pub2

Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users PMID 30521696 https://doi.org/10.1002/14651858.CD009269.pub4

Psychostimulant drugs for cocaine dependence PMID 27670244 https://doi.org/10.1002/14651858.CD007380.pub4

Psychotropic analgesic nitrous oxide for alcoholic withdrawal states PMID 17443576 https://doi.org/10.1002/14651858.CD005190.pub2

QTc interval screening for cardiac risk in methadone treatment of opioid dependence PMID 23787716 https://doi.org/10.1002/14651858.CD008939.pub2

Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents PMID 25369459 https://doi.org/10.1002/14651858.CD010704.pub2

Supervised dosing with a long-acting opioid medication in the management of opioid dependence PMID 28447766 https://doi.org/10.1002/14651858.CD011983.pub2

Sustained-Release Naltrexone For Opioid Dependence PMID 18425938 https://doi.org/10.1002/14651858.CD006140.pub2

Therapeutic communities for substance related disorder PMID 16437526 https://doi.org/10.1002/14651858.CD005338.pub2

Treatment for inhalant dependence and abuse PMID 21154379 https://doi.org/10.1002/14651858.CD007537.pub2

Universal family-based prevention programs for alcohol misuse in young people PMID 21901733 https://doi.org/10.1002/14651858.CD009308

Universal multi-component prevention programs for alcohol misuse in young people PMID 21901732 https://doi.org/10.1002/14651858.CD009307

Universal school-based prevention for illicit drug use PMID 25435250 https://doi.org/10.1002/14651858.CD003020.pub3

Universal school-based prevention programs for alcohol misuse in young people PMID 21563171 https://doi.org/10.1002/14651858.CD009113

Epilepsy Group[edit]

Updated Jan 7 2020

Antidepressant drugs for narcolepsy PMID 18254030 https://doi.org/10.1002/14651858.CD003724.pub3

Antidepressants for people with epilepsy and depression PMID 25464360 https://doi.org/10.1002/14651858.CD010682.pub2

Antiepileptic drugs for preventing seizures in people with brain tumors PMID 18425902 https://doi.org/10.1002/14651858.CD004424.pub2

Antiepileptic drugs for seizure control in people with neurocysticercosis PMID 31608991 https://doi.org/10.1002/14651858.CD009027.pub3

Antiepileptic drugs for treating seizures in adults with brain tumours PMID 21833969 https://doi.org/10.1002/14651858.CD008586.pub2

Brivaracetam add-on therapy for drug-resistant epilepsy PMID 30920649 https://doi.org/10.1002/14651858.CD011501.pub2

Calcium antagonists as an add-on therapy for drug-resistant epilepsy PMID 23543516 https://doi.org/10.1002/14651858.CD002750.pub2

Carbamazepine versus valproate monotherapy for epilepsy: an individual participant data review PMID 10908558 https://doi.org/10.1002/14651858.CD001030

Care delivery and self management strategies for adults with epilepsy PMID 26842929 https://doi.org/10.1002/14651858.CD006244.pub3

Care delivery and self-management strategies for children with epilepsy PMID 29493780 https://doi.org/10.1002/14651858.CD006245.pub4

Chloral hydrate as a sedating agent for neurodiagnostic procedures in children PMID 29099542 https://doi.org/10.1002/14651858.CD011786.pub2

Clobazam add-on therapy for drug-resistant epilepsy PMID 31638272 https://doi.org/10.1002/14651858.CD004154.pub5

Clonazepam add-on therapy for refractory epilepsy in adults and children PMID 29717488 https://doi.org/10.1002/14651858.CD012253.pub2

Clonazepam monotherapy for treating people with newly diagnosed epilepsy PMID 31742671 https://doi.org/10.1002/14651858.CD013028.pub2

Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes PMID 25190506 https://doi.org/10.1002/14651858.CD006779.pub2

Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms PMID 26086765 https://doi.org/10.1002/14651858.CD005222.pub3

Deep brain and cortical stimulation for epilepsy PMID 28718878 https://doi.org/10.1002/14651858.CD008497.pub3

Early versus late antiepileptic drug withdrawal for people with epilepsy in remission PMID 25922863 https://doi.org/10.1002/14651858.CD001902.pub2

EEG for children with complex febrile seizures PMID 28986982 https://doi.org/10.1002/14651858.CD009196.pub4

Eslicarbazepine acetate add-on for drug-resistant focal epilepsy PMID 29067682 https://doi.org/10.1002/14651858.CD008907.pub3

Felbamate add-on therapy for drug-resistant focal epilepsy PMID 31425617 https://doi.org/10.1002/14651858.CD008295.pub5

Gabapentin add-on treatment for drug-resistant focal epilepsy PMID 30357813 https://doi.org/10.1002/14651858.CD001415.pub3

Interventions for psychotic symptoms concomitant with epilepsy PMID 26690687 https://doi.org/10.1002/14651858.CD006118.pub3

Intravenous immunoglobulins for epilepsy PMID 31792946 https://doi.org/10.1002/14651858.CD008557.pub4

Lacosamide add-on therapy for focal epilepsy PMID 26077821 https://doi.org/10.1002/14651858.CD008841.pub2

Lamotrigine add-on therapy for drug-resistant focal epilepsy PMID 27329345 https://doi.org/10.1002/14651858.CD001909.pub2

Lamotrigine add-on therapy for drug-resistant generalized tonic-clonic seizures PMID 21154386 https://doi.org/10.1002/14651858.CD007783.pub2

Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID 29952431 https://doi.org/10.1002/14651858.CD001031.pub4

Losigamone add-on therapy for focal epilepsy PMID 31823350 https://doi.org/10.1002/14651858.CD009324.pub5

Neuropsychological and psychological interventions for people with newly diagnosed epilepsy PMID 26198593 https://doi.org/10.1002/14651858.CD011311.pub2

Non-pharmacological interventions for people with epilepsy and intellectual disabilities PMID 26355236 https://doi.org/10.1002/14651858.CD005502.pub3

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures: an individual participant data review PMID 19821367 https://doi.org/10.1002/14651858.CD006453.pub2

Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review PMID 30350354 https://doi.org/10.1002/14651858.CD003615.pub4

Pharmacological interventions for epilepsy in people with intellectual disabilities PMID 26333428 https://doi.org/10.1002/14651858.CD005399.pub3

Pharmacological treatments for preventing epilepsy following traumatic head injury PMID 26259048 https://doi.org/10.1002/14651858.CD009900.pub2

Polyunsaturated fatty acid supplementation for drug-resistant epilepsy PMID 27536971 https://doi.org/10.1002/14651858.CD011014.pub2

Propofol versus thiopental sodium for the treatment of refractory status epilepticus PMID 28155226 https://doi.org/10.1002/14651858.CD009202.pub4

Psychological and behavioural treatments for adults with non-epileptic attack disorder PMID 24519702 https://doi.org/10.1002/14651858.CD006370.pub2

Rapid versus slow withdrawal of antiepileptic drugs PMID 16625621 https://doi.org/10.1002/14651858.CD005003.pub2

Rufinamide add-on therapy for refractory epilepsy PMID 29691835 https://doi.org/10.1002/14651858.CD011772.pub2

Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy PMID 28157274 https://doi.org/10.1002/14651858.CD008312.pub3

Subpial transection surgery for epilepsy PMID 30383287 https://doi.org/10.1002/14651858.CD008153.pub4

Sulthiame add-on therapy for epilepsy PMID 31453633 https://doi.org/10.1002/14651858.CD009472.pub4

Sulthiame monotherapy for epilepsy PMID 24609897 https://doi.org/10.1002/14651858.CD010062.pub2

Surgery for epilepsy PMID 31237346 https://doi.org/10.1002/14651858.CD010541.pub3

The role of high-frequency oscillations in epilepsy surgery planning PMID 28981957 https://doi.org/10.1002/14651858.CD010235.pub3

Therapeutic monitoring of antiepileptic drugs for epilepsy PMID 17253477 https://doi.org/10.1002/14651858.CD002216.pub2

Tiagabine add-on therapy for drug-resistant focal epilepsy PMID 31608990 https://doi.org/10.1002/14651858.CD001908.pub4

Topiramate add-on therapy for drug-resistant focal epilepsy PMID 31642054 https://doi.org/10.1002/14651858.CD001417.pub4

Topiramate for juvenile myoclonic epilepsy PMID 30687937 https://doi.org/10.1002/14651858.CD010008.pub4

Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID 31233229 https://doi.org/10.1002/14651858.CD012065.pub3

Transcranial magnetic stimulation for the treatment of epilepsy PMID 27513825 https://doi.org/10.1002/14651858.CD011025.pub2

Treatment of epilepsy for people with Alzheimer's disease PMID 30570742 https://doi.org/10.1002/14651858.CD011922.pub3

Treatment of infantile spasms PMID 23740534 https://doi.org/10.1002/14651858.CD001770.pub3

Treatments for seizures in catamenial (menstrual-related) epilepsy PMID 31608992 https://doi.org/10.1002/14651858.CD013225.pub2

Vigabatrin add-on for drug-resistant focal epilepsy PMID 23440814 https://doi.org/10.1002/14651858.CD007302.pub2

Vigabatrin versus carbamazepine monotherapy for epilepsy PMID 26580100 https://doi.org/10.1002/14651858.CD008781.pub3

Zonisamide add-on therapy for focal epilepsy PMID 30335200 https://doi.org/10.1002/14651858.CD001416.pub4

Movement Disorders Group[edit]

Updated Jan 7 2020

Alprazolam for essential tremor PMID 26638213 https://doi.org/10.1002/14651858.CD009681.pub2

 DoneAmantadine in Parkinson's disease PMID 12535476 https://doi.org/10.1002/14651858.CD003468

Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials PMID 22071852 https://doi.org/10.1002/14651858.CD008535.pub2

Beta-blocker therapy for tremor in Parkinson's disease PMID 12535472 https://doi.org/10.1002/14651858.CD003361

Botulinum toxin for masseter hypertrophy PMID 24018587 https://doi.org/10.1002/14651858.CD007510.pub3

Botulinum toxin for motor and phonic tics in Tourette's syndrome PMID 29304272 https://doi.org/10.1002/14651858.CD012285.pub2

Botulinum toxin type A therapy for blepharospasm PMID 15674969 https://doi.org/10.1002/14651858.CD004900.pub2

Botulinum toxin type A therapy for cervical dystonia PMID 29230798 https://doi.org/10.1002/14651858.CD003633.pub3

Botulinum toxin type A versus anticholinergics for cervical dystonia PMID 15674939 https://doi.org/10.1002/14651858.CD004312.pub2

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia PMID 27782297 https://doi.org/10.1002/14651858.CD004314.pub3

Bromocriptine for levodopa-induced motor complications in Parkinson's disease PMID 10796755 https://doi.org/10.1002/14651858.CD001203

Bromocriptine versus levodopa in early Parkinson's disease PMID 17943771 https://doi.org/10.1002/14651858.CD002258.pub2

Cabergoline for levodopa-induced complications in Parkinson's disease PMID 11279720 https://doi.org/10.1002/14651858.CD001518

Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease PMID 11279721 https://doi.org/10.1002/14651858.CD001519

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease PMID 15495119 https://doi.org/10.1002/14651858.CD004554.pub2

Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease PMID 15495118 https://doi.org/10.1002/14651858.CD004553.pub2

Comparison of speech and language therapy techniques for speech problems in Parkinson's disease PMID 22895931 https://doi.org/10.1002/14651858.CD002814.pub2

Deep brain stimulation for dystonia PMID 30629283 https://doi.org/10.1002/14651858.CD012405.pub2

Dopamine agonist therapy in early Parkinson's disease PMID 18425954 https://doi.org/10.1002/14651858.CD006564.pub2

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications PMID 20614454 https://doi.org/10.1002/14651858.CD007166.pub2

Helicobacter pylori eradication for Parkinson's disease PMID 22071847 https://doi.org/10.1002/14651858.CD008453.pub2

Lisuride for levodopa-induced complications in Parkinson's disease PMID 10796801 https://doi.org/10.1002/14651858.CD001515

Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease PMID 10796800 https://doi.org/10.1002/14651858.CD001514

Monoamine oxidase B inhibitors for early Parkinson's disease PMID 16034956 https://doi.org/10.1002/14651858.CD004898.pub2

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease PMID 19821381 https://doi.org/10.1002/14651858.CD006661.pub2

Non-pharmacological therapies for dysphagia in Parkinson's disease PMID 11279766 https://doi.org/10.1002/14651858.CD002816

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies PMID 22071848 https://doi.org/10.1002/14651858.CD008454.pub2

Pergolide for levodopa-induced complications in Parkinson's disease PMID 10796704 https://doi.org/10.1002/14651858.CD000235

Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease PMID 10796705 https://doi.org/10.1002/14651858.CD000236

Physiotherapy for Parkinson's disease: a comparison of techniques PMID 24936965 https://doi.org/10.1002/14651858.CD002815.pub2

Pimozide for tics in Tourette's syndrome PMID 19370666 https://doi.org/10.1002/14651858.CD006996.pub2

Pramipexole for levodopa-induced complications in Parkinson's disease PMID 10908540 https://doi.org/10.1002/14651858.CD002261

Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease PMID 10908539 https://doi.org/10.1002/14651858.CD002259

Pregabalin for essential tremor PMID 27763691 https://doi.org/10.1002/14651858.CD009682.pub2

Ropinirole for levodopa-induced complications in Parkinson's disease PMID 11279718 https://doi.org/10.1002/14651858.CD001516

Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease PMID 11279719 https://doi.org/10.1002/14651858.CD001517

Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease PMID 22895930 https://doi.org/10.1002/14651858.CD002812.pub2

Speech therapy for children with dysarthria acquired before three years of age PMID 27428115 https://doi.org/10.1002/14651858.CD006937.pub3

Surgical treatment for the thumb-in-palm deformity in patients with cerebral palsy PMID 16235349 https://doi.org/10.1002/14651858.CD004093.pub2

Therapeutic interventions for disease progression in Huntington's disease PMID 19588392 https://doi.org/10.1002/14651858.CD006455.pub2

Therapeutic interventions for symptomatic treatment in Huntington's disease PMID 19588393 https://doi.org/10.1002/14651858.CD006456.pub2

Therapies for depression in Parkinson's disease PMID 12917968 https://doi.org/10.1002/14651858.CD003465

Topiramate for essential tremor PMID 28409827 https://doi.org/10.1002/14651858.CD009683.pub2

Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease PMID 27425786 https://doi.org/10.1002/14651858.CD010916.pub2

Treadmill training for patients with Parkinson's disease PMID 26363646 https://doi.org/10.1002/14651858.CD007830.pub4

Zonisamide for essential tremor PMID 28836659 https://doi.org/10.1002/14651858.CD009684.pub2

Multiple Sclerosis and Rare Diseases of the CNS Group[edit]

Updated Jan 7 2020

 Done alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis PMID 29178444 https://doi.org/10.1002/14651858.CD010968.pub2

 Done Azathioprine for multiple sclerosis PMID 17943809 https://doi.org/10.1002/14651858.CD003982.pub2

 Done Corticosteroids or ACTH for acute exacerbations in multiple sclerosis PMID 11034713 https://doi.org/10.1002/14651858.CD001331

 Done Cyclophosphamide for progressive multiple sclerosis PMID 17253481 https://doi.org/10.1002/14651858.CD002819.pub2

 Done Daclizumab for relapsing-remitting multiple sclerosis PMID 24363032 https://doi.org/10.1002/14651858.CD008127.pub4

 Done Dimethyl fumarate for multiple sclerosis PMID 25900414 https://doi.org/10.1002/14651858.CD011076.pub2

 Done Exercise therapy for fatigue in multiple sclerosis PMID 26358158 https://doi.org/10.1002/14651858.CD009956.pub2

 Done Fingolimod for relapsing-remitting multiple sclerosis PMID 27091121 https://doi.org/10.1002/14651858.CD009371.pub2

 Done Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis PMID 23744561 https://doi.org/10.1002/14651858.CD008933.pub2

 Done Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis PMID 26384035 https://doi.org/10.1002/14651858.CD011381.pub2

 Done Information provision for people with multiple sclerosis PMID 30317542 https://doi.org/10.1002/14651858.CD008757.pub3

 Done Interferon in relapsing-remitting multiple sclerosis PMID 11687131 https://doi.org/10.1002/14651858.CD002002

 Done Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis PMID 27880972 https://doi.org/10.1002/14651858.CD009333.pub3

 Done Interventions for preventing falls in people with multiple sclerosis PMID 31778221 https://doi.org/10.1002/14651858.CD012475.pub2

 Done Intravenous immunoglobulin for the treatment of childhood encephalitis PMID 28967695 https://doi.org/10.1002/14651858.CD011367.pub2

 Done Intravenous immunoglobulins for multiple sclerosis PMID 14583956 https://doi.org/10.1002/14651858.CD002936

 Done Laquinimod for multiple sclerosis PMID 23922214 https://doi.org/10.1002/14651858.CD010475.pub2

 Done Mycophenolate mofetil for relapsing-remitting multiple sclerosis PMID 24505016 https://doi.org/10.1002/14651858.CD010242.pub2

 Done Natalizumab for relapsing remitting multiple sclerosis PMID 21975773 https://doi.org/10.1002/14651858.CD007621.pub2

 Done Neuropsychological rehabilitation for multiple sclerosis PMID 24515630 https://doi.org/10.1002/14651858.CD009131.pub3

 Done Non pharmacological interventions for spasticity in multiple sclerosis PMID 23450612 https://doi.org/10.1002/14651858.CD009974.pub2

 Done Non-pharmacological interventions for chronic pain in multiple sclerosis PMID 30567012 https://doi.org/10.1002/14651858.CD012622.pub2

 Done Palliative care interventions for people with multiple sclerosis PMID 31637711 https://doi.org/10.1002/14651858.CD012936.pub2

 Done Prostaglandin E1 for treatment of erectile dysfunction PMID 15106162 https://doi.org/10.1002/14651858.CD001784.pub2

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis PMID 18425915 https://doi.org/10.1002/14651858.CD005278.pub3

Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews PMID 30637728 https://doi.org/10.1002/14651858.CD012732.pub2

Respiratory muscle training for multiple sclerosis PMID 29267988 https://doi.org/10.1002/14651858.CD009424.pub2

Rituximab for relapsing-remitting multiple sclerosis PMID 24310855 https://doi.org/10.1002/14651858.CD009130.pub3

Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection PMID 31163089 https://doi.org/10.1002/14651858.CD012902.pub2

Sodium channel blockers for neuroprotection in multiple sclerosis PMID 26486929 https://doi.org/10.1002/14651858.CD010422.pub2

Statins for multiple sclerosis PMID 22161428 https://doi.org/10.1002/14651858.CD008386.pub3

Treatment of seizures in multiple sclerosis PMID 19588420 https://doi.org/10.1002/14651858.CD007150.pub2

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis PMID 28440858 https://doi.org/10.1002/14651858.CD012200.pub2

Vitamin D for the management of multiple sclerosis PMID 30246874 https://doi.org/10.1002/14651858.CD008422.pub3

Neuromuscular Group[edit]

Updated Jan 7 2020

Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery PMID 29390170 https://doi.org/10.1002/14651858.CD011757.pub2

Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy PMID 31201734 https://doi.org/10.1002/14651858.CD011265.pub2

Antibiotics for the neurological complications of Lyme disease PMID 27931077 https://doi.org/10.1002/14651858.CD006978.pub2

Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease PMID 17253482 https://doi.org/10.1002/14651858.CD002829.pub4

Ascorbic acid for the treatment of Charcot-Marie-Tooth disease PMID 26662471 https://doi.org/10.1002/14651858.CD011952

Assisted standing for Duchenne muscular dystrophy PMID 31606891 https://doi.org/10.1002/14651858.CD011550.pub2

B vitamins for treating peripheral neuropathy other than diabetic and alcohol-related neuropathy PMID 18646107 https://doi.org/10.1002/14651858.CD004573.pub3

Calcium antagonists for Duchenne muscular dystrophy PMID 18843663 https://doi.org/10.1002/14651858.CD004571.pub2

Chinese herbal medicine for diabetic peripheral neuropathy PMID 24096743 https://doi.org/10.1002/14651858.CD007796.pub3

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease PMID 15266526 https://doi.org/10.1002/14651858.CD004302.pub2

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy PMID 29185258 https://doi.org/10.1002/14651858.CD002062.pub4

Corticosteroids for myasthenia gravis PMID 15846640 https://doi.org/10.1002/14651858.CD002828.pub2

Corticosteroids for treating nerve damage in leprosy PMID 27210895 https://doi.org/10.1002/14651858.CD005491.pub3

Decompressive surgery for treating nerve damage in leprosy PMID 23235638 https://doi.org/10.1002/14651858.CD006983.pub3

Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy PMID 18646138 https://doi.org/10.1002/14651858.CD006152.pub2

Drug therapy for chronic idiopathic axonal polyneuropathy PMID 28631805 https://doi.org/10.1002/14651858.CD003456.pub3

Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease PMID 23740607 https://doi.org/10.1002/14651858.CD005226.pub3

Drug treatment for facioscapulohumeral muscular dystrophy PMID 15106171 https://doi.org/10.1002/14651858.CD002276.pub2

Drug treatment for myotonia PMID 16437496 https://doi.org/10.1002/14651858.CD004762.pub2

Endoscopic release for carpal tunnel syndrome PMID 24482073 https://doi.org/10.1002/14651858.CD008265.pub2

Enhanced glucose control for preventing and treating diabetic neuropathy PMID 22696371 https://doi.org/10.1002/14651858.CD007543.pub2

Ergonomic positioning or equipment for treating carpal tunnel syndrome PMID 22259003 https://doi.org/10.1002/14651858.CD009600

Exercise and mobilisation interventions for carpal tunnel syndrome PMID 22696387 https://doi.org/10.1002/14651858.CD009899

Exercise for people with peripheral neuropathy PMID 15495069 https://doi.org/10.1002/14651858.CD003904.pub2

Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease PMID 28067943 https://doi.org/10.1002/14651858.CD006049.pub2

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID 28481421 https://doi.org/10.1002/14651858.CD003280.pub5

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis PMID 22895935 https://doi.org/10.1002/14651858.CD003643.pub4

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy PMID 25739040 https://doi.org/10.1002/14651858.CD003217.pub5

Immunosuppressive agents for myasthenia gravis PMID 17943844 https://doi.org/10.1002/14651858.CD005224.pub2

Immunosuppressive treatment for non-systemic vasculitic neuropathy PMID 17253577 https://doi.org/10.1002/14651858.CD006050.pub2

Immunotherapy for diabetic amyotrophy PMID 28746752 https://doi.org/10.1002/14651858.CD006521.pub4

Immunotherapy for idiopathic lumbosacral plexopathy PMID 24379134 https://doi.org/10.1002/14651858.CD009722.pub2

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies PMID 27701752 https://doi.org/10.1002/14651858.CD002827.pub4

Interventions for dysphagia in long-term, progressive muscle disease PMID 26859621 https://doi.org/10.1002/14651858.CD004303.pub4

Interventions for fatigue in peripheral neuropathy PMID 25519471 https://doi.org/10.1002/14651858.CD008146.pub2

Interventions for idiopathic toe walking PMID 31587271 https://doi.org/10.1002/14651858.CD012363.pub2

Interventions for increasing ankle range of motion in patients with neuromuscular disease PMID 20166090 https://doi.org/10.1002/14651858.CD006973.pub2

Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy PMID 30326162 https://doi.org/10.1002/14651858.CD009068.pub3

Interventions for preventing critical illness polyneuropathy and critical illness myopathy PMID 24477672 https://doi.org/10.1002/14651858.CD006832.pub3

Interventions for preventing neuropathy caused by cisplatin and related compounds PMID 24687190 https://doi.org/10.1002/14651858.CD005228.pub4

Interventions for the treatment of Morton's neuroma PMID 15266472 https://doi.org/10.1002/14651858.CD003118.pub2

Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy PMID 28117876 https://doi.org/10.1002/14651858.CD010899.pub2

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy PMID 24379104 https://doi.org/10.1002/14651858.CD001797.pub3

Intravenous immunoglobulin for multifocal motor neuropathy PMID 15846714 https://doi.org/10.1002/14651858.CD004429.pub2

Intravenous immunoglobulin for myasthenia gravis PMID 23235588 https://doi.org/10.1002/14651858.CD002277.pub4

Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders PMID 29199768 https://doi.org/10.1002/14651858.CD008380.pub2

Low-level laser therapy for carpal tunnel syndrome PMID undefined https://doi.org/10.1002/14651858.CD012765

Magnesium for skeletal muscle cramps PMID 22972143 https://doi.org/10.1002/14651858.CD009402.pub2

Mechanical insufflation-exsufflation for people with neuromuscular disorders PMID 24374746 https://doi.org/10.1002/14651858.CD010044.pub2

Medical and surgical treatment for ocular myasthenia PMID 23235620 https://doi.org/10.1002/14651858.CD005081.pub3

Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease PMID 19821416 https://doi.org/10.1002/14651858.CD007425.pub2

Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders PMID 25503955 https://doi.org/10.1002/14651858.CD001941.pub3

Non-antiepileptic drugs for trigeminal neuralgia PMID 24297506 https://doi.org/10.1002/14651858.CD004029.pub4

Non-drug therapies for lower limb muscle cramps PMID 22258986 https://doi.org/10.1002/14651858.CD008496.pub2

Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) PMID 25391139 https://doi.org/10.1002/14651858.CD003458.pub5

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome PMID 27846348 https://doi.org/10.1002/14651858.CD008630.pub4

Pharmacological treatments for Friedreich ataxia PMID 27572719 https://doi.org/10.1002/14651858.CD007791.pub4

Physical exercise training for type 3 spinal muscular atrophy PMID 30821348 https://doi.org/10.1002/14651858.CD012120.pub2

Physical rehabilitation for critical illness myopathy and neuropathy PMID 25737049 https://doi.org/10.1002/14651858.CD010942.pub2

Physical training for McArdle disease PMID 22161416 https://doi.org/10.1002/14651858.CD007931.pub2

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID 26305459 https://doi.org/10.1002/14651858.CD003906.pub4

Plasma exchange for generalised myasthenia gravis PMID 12519572 https://doi.org/10.1002/14651858.CD002275

Plasma exchange for Guillain-Barré syndrome PMID 28241090 https://doi.org/10.1002/14651858.CD001798.pub3

Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy PMID 16855999 https://doi.org/10.1002/14651858.CD003218.pub2

Quinine for muscle cramps PMID 25842375 https://doi.org/10.1002/14651858.CD005044.pub3

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease PMID 23152212 https://doi.org/10.1002/14651858.CD002064.pub3

Rehabilitation following carpal tunnel release PMID 26884379 https://doi.org/10.1002/14651858.CD004158.pub3

Respiratory muscle training in children and adults with neuromuscular disease PMID 31487757 https://doi.org/10.1002/14651858.CD011711.pub2

Scapular fixation in muscular dystrophy PMID 20091543 https://doi.org/10.1002/14651858.CD003278.pub2

Splinting for carpal tunnel syndrome PMID 22786532 https://doi.org/10.1002/14651858.CD010003

Surgery for scoliosis in Duchenne muscular dystrophy PMID 26423318 https://doi.org/10.1002/14651858.CD005375.pub4

Surgical versus non-surgical treatment for carpal tunnel syndrome PMID 18843618 https://doi.org/10.1002/14651858.CD001552.pub2

Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease PMID 28072907 https://doi.org/10.1002/14651858.CD011776.pub2

Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease PMID 23728653 https://doi.org/10.1002/14651858.CD005229.pub3

Therapeutic ultrasound for carpal tunnel syndrome PMID 23543580 https://doi.org/10.1002/14651858.CD009601.pub2

Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection PMID 25525951 https://doi.org/10.1002/14651858.CD010404.pub2

Treatment for familial amyotrophic lateral sclerosis/motor neuron disease PMID 19160266 https://doi.org/10.1002/14651858.CD006153.pub2

Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders PMID 17253522 https://doi.org/10.1002/14651858.CD004761.pub2

Treatment for IgG and IgA paraproteinaemic neuropathy PMID 25803231 https://doi.org/10.1002/14651858.CD005376.pub3

Treatment for inclusion body myositis PMID undefined https://doi.org/10.1002/14651858.CD001555.pub5

Treatment for meralgia paraesthetica PMID 23235604 https://doi.org/10.1002/14651858.CD004159.pub3

Treatment for paraneoplastic neuropathies PMID 23235647 https://doi.org/10.1002/14651858.CD007625.pub2

Treatment for periodic paralysis PMID 18254068 https://doi.org/10.1002/14651858.CD005045.pub2

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome PMID 22696361 https://doi.org/10.1002/14651858.CD006828.pub3

Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease PMID 22336799 https://doi.org/10.1002/14651858.CD004156.pub4

Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease PMID 29293261 https://doi.org/10.1002/14651858.CD011005.pub2

Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews PMID 28084646 https://doi.org/10.1002/14651858.CD010369.pub2

Treatments other than ascorbic acid for Charcot-Marie-Tooth disease PMID 18254090 https://doi.org/10.1002/14651858.CD006052.pub2

Schizophrenia Group[edit]

SEED Project Links[edit]

Schmidt et al 2017, Syst Rev: SEED: a tool for disseminating systematic review data into Wikipedia

List of Schizophrenia Reviews not yet included in Wikipedia[edit]

updated Jan 7 2020

Acetylsalicylic acid (aspirin) for schizophrenia PMID 31425623 https://doi.org/10.1002/14651858.CD012116.pub2

Advance treatment directives for people with severe mental illness PMID 19160260 https://doi.org/10.1002/14651858.CD005963.pub2

Amisulpride for schizophrenia PMID 12076408 https://doi.org/10.1002/14651858.CD001357

Amphetamines for schizophrenia PMID 15495131 https://doi.org/10.1002/14651858.CD004964

Anticholinergic medication for antipsychotic-induced tardive dyskinesia PMID 29341071 https://doi.org/10.1002/14651858.CD000204.pub2

Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia PMID 24353163 https://doi.org/10.1002/14651858.CD009546.pub2

Anticholinergics for neuroleptic-induced acute akathisia PMID 17054182 https://doi.org/10.1002/14651858.CD003727.pub3

Antidepressants for people with both schizophrenia and depression PMID 12076447 https://doi.org/10.1002/14651858.CD002305

Antidepressants for the negative symptoms of schizophrenia PMID 16856105 https://doi.org/10.1002/14651858.CD005581.pub2

Antiglucocorticoid and related treatments for psychosis PMID 26725721 https://doi.org/10.1002/14651858.CD006995.pub2

Antioxidant treatments for schizophrenia PMID 26848926 https://doi.org/10.1002/14651858.CD008919.pub2

Antipsychotic combinations for schizophrenia PMID 28658515 https://doi.org/10.1002/14651858.CD009005.pub2

Antipsychotic drug treatment for elderly people with late-onset schizophrenia PMID 22336800 https://doi.org/10.1002/14651858.CD004162.pub2

Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum PMID 15106251 https://doi.org/10.1002/14651858.CD004411.pub2

Antipsychotic medication for childhood-onset schizophrenia PMID 17636744 https://doi.org/10.1002/14651858.CD004027.pub2

Antipsychotic medication for early episode schizophrenia PMID 21678355 https://doi.org/10.1002/14651858.CD006374.pub2

Antipsychotic medication for elderly people with schizophrenia PMID 16437531 https://doi.org/10.1002/14651858.CD005580

Antipsychotic medication versus placebo for people with both schizophrenia and learning disability PMID 15494985 https://doi.org/10.1002/14651858.CD000030.pub2

Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia PMID 29409162 https://doi.org/10.1002/14651858.CD000459.pub3

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems PMID 21154372 https://doi.org/10.1002/14651858.CD006629.pub2

Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation) PMID 29308601 https://doi.org/10.1002/14651858.CD008074.pub2

Aripiprazole for schizophrenia PMID 16625607 https://doi.org/10.1002/14651858.CD004578.pub3

Aripiprazole versus typical antipsychotic drugs for schizophrenia PMID 18646161 https://doi.org/10.1002/14651858.CD006617.pub3

'As required' medication regimens for seriously mentally ill people in hospital PMID 26689942 https://doi.org/10.1002/14651858.CD003441.pub3

Atypical antipsychotics for people with both schizophrenia and depression PMID 18254078 https://doi.org/10.1002/14651858.CD005377.pub2

Ayurvedic medicine for schizophrenia PMID 17943922 https://doi.org/10.1002/14651858.CD006867

Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses PMID 31425609 https://doi.org/10.1002/14651858.CD006570.pub3

Benzodiazepines for neuroleptic-induced acute akathisia PMID 11869614 https://doi.org/10.1002/14651858.CD001950

Benzodiazepines for schizophrenia PMID 23152236 https://doi.org/10.1002/14651858.CD006391.pub2

Beta-adrenergic blocking agents (beta blockers) for people with schizophrenia PMID 10796332 https://doi.org/10.1002/14651858.CD000234

Bifeprunox versus placebo for schizophrenia PMID 27732740 https://doi.org/10.1002/14651858.CD012029.pub2

Bromperidol decanoate (depot) for schizophrenia PMID 23152208 https://doi.org/10.1002/14651858.CD001719.pub4

Carbamazepine for schizophrenia PMID 24789267 https://doi.org/10.1002/14651858.CD001258.pub3

Cessation of medication for people with schizophrenia already stable on chlorpromazine PMID 17253586 https://doi.org/10.1002/14651858.CD006329

Chinese herbal medicine for schizophrenia PMID 16235320 https://doi.org/10.1002/14651858.CD003444.pub2

Chlorpromazine dose for people with schizophrenia PMID 28407198 https://doi.org/10.1002/14651858.CD007778.pub2

Chlorpromazine for psychosis-induced aggression or agitation PMID 20393959 https://doi.org/10.1002/14651858.CD007445.pub2

Chlorpromazine versus atypical antipsychotic drugs for schizophrenia PMID 27045703 https://doi.org/10.1002/14651858.CD010631.pub2

Chlorpromazine versus clotiapine for schizophrenia PMID 28387925 https://doi.org/10.1002/14651858.CD011810.pub2

Chlorpromazine versus penfluridol for schizophrenia PMID 28940256 https://doi.org/10.1002/14651858.CD011831.pub2

Chlorpromazine versus piperacetazine for schizophrenia PMID 30378678 https://doi.org/10.1002/14651858.CD011709.pub2

Cholinergic medication for antipsychotic-induced tardive dyskinesia PMID 29553158 https://doi.org/10.1002/14651858.CD000207.pub2

Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia PMID 28333365 https://doi.org/10.1002/14651858.CD006324.pub3

Clozapine dose for schizophrenia PMID 28613395 https://doi.org/10.1002/14651858.CD009555.pub2

Clozapine versus other atypical antipsychotics for schizophrenia PMID 21069690 https://doi.org/10.1002/14651858.CD006633.pub2

Cognitive behavioural therapy (brief versus standard duration) for schizophrenia PMID 26488686 https://doi.org/10.1002/14651858.CD010646.pub3

Cognitive rehabilitation for people with schizophrenia and related conditions PMID 10908479 https://doi.org/10.1002/14651858.CD000968

Collaborative care approaches for people with severe mental illness PMID 24190251 https://doi.org/10.1002/14651858.CD009531.pub2

Communication skills training for mental health professionals working with people with severe mental illness PMID 28613384 https://doi.org/10.1002/14651858.CD010006.pub2

Community mental health teams for people with severe mental illnesses PMID 17636625 https://doi.org/10.1002/14651858.CD000270.pub2

Containment strategies for people with serious mental illness PMID 16855984 https://doi.org/10.1002/14651858.CD002084.pub2

Crisis intervention for people with severe mental illnesses PMID 26633650 https://doi.org/10.1002/14651858.CD001087.pub5

Dance therapy for schizophrenia PMID 24092546 https://doi.org/10.1002/14651858.CD006868.pub3

Day centres for severe mental illness PMID 17253463 https://doi.org/10.1002/14651858.CD001710.pub2

Day hospital versus admission for acute psychiatric disorders PMID 22161384 https://doi.org/10.1002/14651858.CD004026.pub2

Day hospital versus outpatient care for people with schizophrenia PMID 19821303 https://doi.org/10.1002/14651858.CD003240.pub2

De-escalation techniques for psychosis-induced aggression or agitation PMID 28368091 https://doi.org/10.1002/14651858.CD009922.pub2

Depot haloperidol decanoate for schizophrenia PMID 10796438 https://doi.org/10.1002/14651858.CD001361

Depot perphenazine decanoate and enanthate for schizophrenia PMID 16034865 https://doi.org/10.1002/14651858.CD001717.pub2

Dietary advice for people with schizophrenia PMID 27007216 https://doi.org/10.1002/14651858.CD009547.pub2

Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders PMID 29064090 https://doi.org/10.1002/14651858.CD011707.pub2

Distraction techniques for schizophrenia PMID 15674963 https://doi.org/10.1002/14651858.CD004717.pub2

Droperidol for psychosis-induced aggression or agitation PMID 27976370 https://doi.org/10.1002/14651858.CD002830.pub3

Electroconvulsive therapy for treatment-resistant schizophrenia PMID 30888709 https://doi.org/10.1002/14651858.CD011847.pub2

Family intervention (brief) for schizophrenia PMID 24595545 https://doi.org/10.1002/14651858.CD009802.pub2

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders PMID 24915451 https://doi.org/10.1002/14651858.CD001470.pub2

Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25177834 https://doi.org/10.1002/14651858.CD009227.pub2

Fluphenazine (oral) versus atypical antipsychotics for schizophrenia PMID 27370402 https://doi.org/10.1002/14651858.CD010832.pub2

Fluphenazine decanoate (depot) and enanthate for schizophrenia PMID 25654768 https://doi.org/10.1002/14651858.CD000307.pub2

General physical health advice for people with serious mental illness PMID 24676557 https://doi.org/10.1002/14651858.CD008567.pub3

Haloperidol discontinuation for people with schizophrenia PMID 31006114 https://doi.org/10.1002/14651858.CD011408.pub2

Haloperidol dose for the acute phase of schizophrenia PMID 23983042 https://doi.org/10.1002/14651858.CD001951.pub2

Haloperidol for long-term aggression in psychosis PMID 27889922 https://doi.org/10.1002/14651858.CD009830.pub2

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders PMID 25592299 https://doi.org/10.1002/14651858.CD009831.pub2

Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25007358 https://doi.org/10.1002/14651858.CD009268.pub2

HIV prevention advice for people with serious mental illness PMID 27609030 https://doi.org/10.1002/14651858.CD009639.pub3

Horticultural therapy for schizophrenia PMID 24842458 https://doi.org/10.1002/14651858.CD009413.pub2

Hypnosis for schizophrenia PMID 17943812 https://doi.org/10.1002/14651858.CD004160.pub3

Implementation of treatment guidelines for specialist mental health care PMID 27977851 https://doi.org/10.1002/14651858.CD009780.pub3

Increasing antipsychotic dose for non response in schizophrenia PMID 29750432 https://doi.org/10.1002/14651858.CD011883.pub2

Information and communication technology based prompting for treatment compliance for people with serious mental illness PMID 24934254 https://doi.org/10.1002/14651858.CD009960.pub2

Information and communication technology in patient education and support for people with schizophrenia PMID 23076932 https://doi.org/10.1002/14651858.CD007198.pub2

Intermittent drug techniques for schizophrenia PMID 23881657 https://doi.org/10.1002/14651858.CD006196.pub2

Interventions for prodromal stage of psychosis PMID 31689359 https://doi.org/10.1002/14651858.CD012236.pub2

Interventions to encourage uptake of cancer screening for people with severe mental illness PMID 27668891 https://doi.org/10.1002/14651858.CD009641.pub3

Interventions to reduce weight gain in schizophrenia PMID 17253540 https://doi.org/10.1002/14651858.CD005148.pub2

Lamotrigine augmentation for treatment-resistant schizophrenia PMID 17054266 https://doi.org/10.1002/14651858.CD005962.pub2

Length of hospitalisation for people with severe mental illness PMID 24477710 https://doi.org/10.1002/14651858.CD000384.pub3

Lithium for schizophrenia PMID 26509923 https://doi.org/10.1002/14651858.CD003834.pub3

Management of sexual dysfunction due to antipsychotic drug therapy PMID 23152218 https://doi.org/10.1002/14651858.CD003546.pub3

Mirtazapine adjunct for people with schizophrenia PMID 29802811 https://doi.org/10.1002/14651858.CD011943.pub2

Miscellaneous treatments for antipsychotic-induced tardive dyskinesia PMID 29552749 https://doi.org/10.1002/14651858.CD000208.pub2

Modafinil for people with schizophrenia or related disorders PMID 31828767 https://doi.org/10.1002/14651858.CD008661.pub2

Monetary incentives for schizophrenia PMID 19821433 https://doi.org/10.1002/14651858.CD007626.pub2

Morita therapy for schizophrenia PMID 17253588 https://doi.org/10.1002/14651858.CD006346

Mother and baby units for non-affective psychosis during pregnancy and postpartum PMID 17253587 https://doi.org/10.1002/14651858.CD006333

New generation antipsychotics for first episode schizophrenia PMID 14584012 https://doi.org/10.1002/14651858.CD004410

Newer atypical antipsychotic medication versus clozapine for schizophrenia PMID 10796559 https://doi.org/10.1002/14651858.CD000966

Nicotine for schizophrenia PMID 16437497 https://doi.org/10.1002/14651858.CD004838.pub2

Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia PMID 29342497 https://doi.org/10.1002/14651858.CD000458.pub3

Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia PMID 30293234 https://doi.org/10.1002/14651858.CD012398.pub2

Oestrogen for schizophrenia PMID 16235377 https://doi.org/10.1002/14651858.CD004719.pub2

Olanzapine (intramuscular or velotab) for acutely disturbed/agitated people with suspected serious mental illnesses PMID 15846678 https://doi.org/10.1002/14651858.CD003729.pub2

Open general medical wards versus specialist psychiatric units for acute psychoses PMID 17943786 https://doi.org/10.1002/14651858.CD003290.pub2

Oral health education (advice and training) for people with serious mental illness PMID 27606629 https://doi.org/10.1002/14651858.CD008802.pub3

Outcome measures and needs assessment tools for schizophrenia and related disorders PMID 12535453 https://doi.org/10.1002/14651858.CD003081

Paliperidone (oral) for schizophrenia PMID 18425951 https://doi.org/10.1002/14651858.CD006369.pub2

Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25290157 https://doi.org/10.1002/14651858.CD009369.pub2

Pharmacological interventions for clozapine-induced sinus tachycardia PMID 27277334 https://doi.org/10.1002/14651858.CD011566.pub2

Pharmacological treatments for psychosis-related polydipsia PMID 17054176 https://doi.org/10.1002/14651858.CD003544.pub2

Physical health care monitoring for people with serious mental illness PMID 24442580 https://doi.org/10.1002/14651858.CD008298.pub3

Preventive interventions for postnatal psychosis PMID 23740790 https://doi.org/10.1002/14651858.CD009991.pub2

Problem solving skills for schizophrenia PMID 17443621 https://doi.org/10.1002/14651858.CD006365.pub2

Prompts to encourage appointment attendance for people with serious mental illness PMID 11406031 https://doi.org/10.1002/14651858.CD002085

Psychoeducation (brief) for people with serious mental illness PMID 25854522 https://doi.org/10.1002/14651858.CD010823.pub2

Psychoeducation for schizophrenia PMID 21678337 https://doi.org/10.1002/14651858.CD002831.pub2

Psychoeducation for siblings of people with severe mental illness PMID 25953641 https://doi.org/10.1002/14651858.CD010540.pub2

Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness PMID 28116752 https://doi.org/10.1002/14651858.CD011464.pub2

Psychosocial interventions for people with both severe mental illness and substance misuse PMID 31829430 https://doi.org/10.1002/14651858.CD001088.pub4

Risperidone (depot) for schizophrenia PMID 27078222 https://doi.org/10.1002/14651858.CD004161.pub2

Risperidone dose for schizophrenia PMID 19821422 https://doi.org/10.1002/14651858.CD007474.pub2

Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation) PMID 29634083 https://doi.org/10.1002/14651858.CD009412.pub2

Risperidone versus olanzapine for people with schizophrenia PMID 16625629 https://doi.org/10.1002/14651858.CD005237.pub2

Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse PMID 29355909 https://doi.org/10.1002/14651858.CD011057.pub2

Risperidone versus typical antipsychotic medication for schizophrenia PMID 10796543 https://doi.org/10.1002/14651858.CD000440

Seclusion and restraint for people with serious mental illnesses PMID 10796606 https://doi.org/10.1002/14651858.CD001163

Sertindole versus other atypical antipsychotics for schizophrenia PMID 19370652 https://doi.org/10.1002/14651858.CD006752.pub2

Smoking cessation advice for people with serious mental illness PMID 26816385 https://doi.org/10.1002/14651858.CD009704.pub2

Social skills programmes for schizophrenia PMID 26059249 https://doi.org/10.1002/14651858.CD009006.pub2

Supported housing for people with severe mental disorders PMID 17054130 https://doi.org/10.1002/14651858.CD000453.pub2

Testosterone for schizophrenia PMID 17636833 https://doi.org/10.1002/14651858.CD006197.pub2

Training to recognise the early signs of recurrence in schizophrenia PMID 23450559 https://doi.org/10.1002/14651858.CD005147.pub2

Treatments for delusional disorder PMID 25997589 https://doi.org/10.1002/14651858.CD009785.pub2

Treatments for primary delusional infestation PMID 31821546 https://doi.org/10.1002/14651858.CD011326.pub2

Twenty-four hour care for schizophrenia PMID 19370601 https://doi.org/10.1002/14651858.CD004409.pub2

User-held personalised information for routine care of people with severe mental illness PMID 24096715 https://doi.org/10.1002/14651858.CD001711.pub2

Virtual reality for treatment compliance for people with serious mental illness PMID 25300174 https://doi.org/10.1002/14651858.CD009928.pub2

Vocational rehabilitation for people with severe mental illness PMID 11406069 https://doi.org/10.1002/14651858.CD003080

Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis PMID 26252640 https://doi.org/10.1002/14651858.CD011021.pub2

 DoneWendan decoction (Traditional Chinese medicine) for schizophrenia PMID 28657646 https://doi.org/10.1002/14651858.CD012217.pub2

Yoga as part of a package of care versus non-standard care for schizophrenia PMID 30990224 https://doi.org/10.1002/14651858.CD012807.pub2

Yoga as part of a package of care versus standard care for schizophrenia PMID 28960019 https://doi.org/10.1002/14651858.CD012145.pub2

Yoga versus standard care for schizophrenia PMID 26488850 https://doi.org/10.1002/14651858.CD010554.pub2

Ziprasidone for schizophrenia and severe mental illness PMID 11034737 https://doi.org/10.1002/14651858.CD001945

Ziprasidone versus other atypical antipsychotics for schizophrenia PMID 19821380 https://doi.org/10.1002/14651858.CD006627.pub2

Zotepine for schizophrenia PMID 17054149 https://doi.org/10.1002/14651858.CD001948.pub2

Zotepine versus other atypical antipsychotics for schizophrenia PMID 20927748 https://doi.org/10.1002/14651858.CD006628.pub3

Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses PMID 22513898 https://doi.org/10.1002/14651858.CD000525.pub3

Zuclopenthixol versus placebo for schizophrenia PMID 26624987 https://doi.org/10.1002/14651858.CD010598.pub2